Nantahala lists 9.99% stake in Envoy Medical

Rhea-AI Filing Summary

Envoy Medical, Inc. Schedule 13G reports that Nantahala Capital Management, LLC and its managing members, Wilmot B. Harkey and Daniel Mack, may be deemed beneficial owners of 7,683,798 shares of Class A Common Stock, representing 9.99% of the class as of March 31, 2026. The disclosed holdings include 33,798 shares that may be acquired within sixty days through the exercise of convertible securities. The filing shows shared voting and dispositive power over the 7,683,798 shares and reports no sole voting or dispositive power.

Insights

Governance & Ownership Analyst

Holders report a near-10% passive stake with shared control over holdings.

The filing states Nantahala and its principals beneficially own 7,683,798 shares (9.99%) as of March 31, 2026, with shared voting and dispositive power. This indicates coordinated ownership through an investment-advisory structure rather than sole control.

Key dependencies include the convertible securities that allow acquisition of 33,798 shares within sixty days and any future amendments to ownership percentages; subsequent filings will disclose changes in position.

Institutional Investor Relations Specialist

Stake size is material for disclosure but does not by itself alter governance control.

The filing attributes shared voting and dispositive authority to Nantahala and names Messrs. Harkey and Mack as control persons; it does not report sole voting power. The structure is typical for an investment adviser managing client accounts.

Cash-flow treatment or plans to buy/sell are not stated in the excerpt; future Schedule 13D/13G or Form 4 filings would reflect any active changes.

Key Figures

Beneficial ownership: 7,683,798 shares Percent of class: 9.99% Shares exercisable within 60 days: 33,798 shares

3 metrics

Beneficial ownership 7,683,798 shares As of March 31, 2026

Percent of class 9.99% As of March 31, 2026

Shares exercisable within 60 days 33,798 shares Included in the 7,683,798 total

Key Terms

beneficial owner, shared dispositive power, convertible securities

3 terms

beneficial owner regulatory

"Nantahala may be deemed to be the beneficial owner of 7,683,798 Shares"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

shared dispositive power regulatory

"Shared Dispositive Power 7,683,798.00"

convertible securities financial

"Include 33,798 Shares which may be acquired ... through the exercise of convertible securities"

Convertible securities are bonds or preferred shares that can be exchanged for a company’s common stock at a predetermined price or under specified conditions. They matter because they combine the steadiness of a loan or fixed dividend with the potential upside of ownership; like a safety‑net that carries a one‑time ticket to become a shareholder, they affect expected returns and can dilute existing stock if converted.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Nantahala list in Envoy Medical (COCH)?

Nantahala reports beneficial ownership of 7,683,798 shares, equal to 9.99% of Class A Common Stock as of March 31, 2026. The filing attributes shared voting and dispositive power over those shares to Nantahala and the two named principals.

Do the Reporting Persons have sole voting or dispositive power?

No. The Schedule 13G states each Reporting Person has 0 sole voting and 0 sole dispositive power. The filing records shared voting and shared dispositive power for 7,683,798 shares among the Reporting Persons.

Are any additional shares exercisable soon by the Reporting Persons?

Yes. The filing discloses that the 7,683,798 shares include 33,798 shares that may be acquired within sixty days upon exercise of convertible securities. The filing ties that exercisable amount to the total beneficial ownership figure.

Does this Schedule 13G indicate the Reporting Persons will change control?

No explicit change-of-control action is stated. The Schedule 13G reports passive beneficial ownership and shared powers; it does not state any transaction plan or intent to alter governance in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:41 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ENVOY MEDICAL, INC.

(Name of Issuer)

Class A Common Stock, par value $0.0001 per share

(Title of Class of Securities)

29415V109

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 29415V109

1

Names of Reporting Persons

Nantahala Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MASSACHUSETTS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,683,798.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,683,798.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,683,798.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 29415V109

1

Names of Reporting Persons

Wilmot B. Harkey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,683,798.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,683,798.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,683,798.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): 29415V109

1

Names of Reporting Persons

Daniel Mack

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 7,683,798.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,683,798.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,683,798.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ENVOY MEDICAL, INC.
(b)	Address of issuer's principal executive offices: 4875 WHITE BEAR PARKWAY WHITE BEAR LAKE, MINNESOTA, 55110
Item 2.
(a)	Name of person filing: (1) Nantahala Capital Management, LLC ("Nantahala") (2) Wilmot B. Harkey (3) Daniel Mack (together the "Reporting Persons")
(b)	Address or principal business office or, if none, residence: 130 Main St. 2nd Floor, New Canaan, Connecticut 06840
(c)	Citizenship: (1) Nantahala is a Massachusetts limited liability company. (2) Each of Messrs. Harkey and Mack is a citizen of the United States of America.
(d)	Title of class of securities: Class A Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 29415V109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of March 31, 2026, Nantahala may be deemed to be the beneficial owner of 7,683,798 Shares held by funds and separately managed accounts under its control, and as the managing members of Nantahala, each of Messrs. Harkey and Mack may be deemed to be a beneficial owner of those Shares. The 7,683,798 Shares Include 33,798 Shares which may be acquired by the Reporting Persons within sixty days through the exercise of convertible securities.
(b)	Percent of class: As of March 31, 2026, each of the Reporting Persons may be deemed to be the beneficial owner of the following percentage of the total number of Shares outstanding: (1) Nantahala Capital Management, LLC ("Nantahala") : 9.99% (2) Wilmot B. Harkey: 9.99% (3) Daniel Mack: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (1) Nantahala Capital Management, LLC ("Nantahala") : 0 Shares. (2) Wilmot B. Harkey: 0 Shares. (3) Daniel Mack: 0 Shares.
	(ii) Shared power to vote or to direct the vote: (1) Nantahala Capital Management, LLC ("Nantahala") : 7,683,798 Shares. (2) Wilmot B. Harkey: 7,683,798 Shares. (3) Daniel Mack: 7,683,798 Shares.
	(iii) Sole power to dispose or to direct the disposition of: (1) Nantahala Capital Management, LLC ("Nantahala") : 0 Shares. (2) Wilmot B. Harkey: 0 Shares. (3) Daniel Mack: 0 Shares.
	(iv) Shared power to dispose or to direct the disposition of: (1) Nantahala Capital Management, LLC ("Nantahala") : 7,683,798 Shares. (2) Wilmot B. Harkey: 7,683,798 Shares. (3) Daniel Mack: 7,683,798 Shares.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Each of Messrs. Harkey and Mack is filing this Schedule 13G as a control person in respect of shares beneficially owned by Nantahala, an investment adviser as described in ss. 240.13d-1(b)(1)(ii)(E). See Item 4(a).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Nantahala Capital Management, LLC

Signature:	/s/ Taki Vasilakis
Name/Title:	Taki Vasilakis / Chief Compliance Officer
Date:	05/15/2026

Wilmot B. Harkey

Signature:	/s/ Wilmot B. Harkey
Name/Title:	Wilmot B. Harkey
Date:	05/15/2026

Daniel Mack

Signature:	/s/ Daniel Mack
Name/Title:	Daniel Mack
Date:	05/15/2026